Deal, A., Ginos, B., Schrag, D., Jansen, J., Henson, S., Stover, A., … Blinder, V. (2024). Electronic Symptom Monitoring During Metastatic Cancer Treatment: Does it work better for some patients than for others (AFT-39)? In QUALITY OF LIFE RESEARCH (Vol. 33, pp. S104–S105).

Deal, Allison, Brenda Ginos, Deborah Schrag, Jennifer Jansen, Sydney Henson, Angela Stover, Philip Carr, et al. “Electronic Symptom Monitoring During Metastatic Cancer Treatment: Does it work better for some patients than for others (AFT-39)?” In QUALITY OF LIFE RESEARCH, 33:S104–5, 2024.

Deal A, Ginos B, Schrag D, Jansen J, Henson S, Stover A, et al. Electronic Symptom Monitoring During Metastatic Cancer Treatment: Does it work better for some patients than for others (AFT-39)? In: QUALITY OF LIFE RESEARCH. 2024. p. S104–5.

Deal, Allison, et al. “Electronic Symptom Monitoring During Metastatic Cancer Treatment: Does it work better for some patients than for others (AFT-39)?” QUALITY OF LIFE RESEARCH, vol. 33, 2024, pp. S104–05.

Deal A, Ginos B, Schrag D, Jansen J, Henson S, Stover A, Carr P, Spears P, Jonsson M, Bennett A, Thanarajasingam G, Rogak L, Reeve B, Snyder C, Bruner D, Cella D, Kottschade L, Perlmutter J, Geoghegan C, Given B, Mazza G, Miller R, Strasser J, Zylla D, Weiss A, Wolf A, Dueck A, Basch E, Blinder V. Electronic Symptom Monitoring During Metastatic Cancer Treatment: Does it work better for some patients than for others (AFT-39)? QUALITY OF LIFE RESEARCH. 2024. p. S104–S105.